Skip to main content
Veterinary Medicines

LIBEO 40 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Furosemide

Product identification

Medicine name:
LIBEO 40 MG COMPRIMES A CROQUER POUR CHIENS
LIBEO 40 MG CHEWABLE TABLETS FOR DOGS
Active substance:
  • Furosemide
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Cardboard box containing 1 blister of 8 tablets
  • Cardboard box containing 25 blisters of 8 tablets
  • Cardboard box containing 15 blisters of 8 tablets
  • Cardboard box containing 12 blisters of 8 tablets
  • Cardboard box containing 2 blisters of 8 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • CEVA Santé Animale
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6241623 6/2013
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0252/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 25/03/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 25/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."